Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms

Science Immunology(2024)10.1126/sciimmunol.adn9879Source: DataRank Database

Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms is a research paper published in Science Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 11.75)OA: bronzeTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Zaofeng Yang ORCID,Thomas Savage ORCID,Rosa L. Vincent ORCID,Kenia de los Santos-Alexis ORCID,Alexander Ahn ORCID

Live enrichment

PubMed:39423284 PMC:PMC11984541 OpenAlex:https://openalex.org/W4403533741

NCI NIH HHS

Grant: R01 CA259634

NCI NIH HHS

Grant: R01 CA249160

FWCI

11.75

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

bronze

journalhttps://www.science.org/doi/pdf/10.1126/sciimmunol.adn9879?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.adn9879?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.adn9879

journalhttps://doi.org/10.1126/sciimmunol.adn9879

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39423284

Fields of Study

Cancer Research and TreatmentsCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

MeSH Terms

Immune Checkpoint InhibitorsAnimalsFemaleHumansImmunotherapyInterferon-gammaMice, Inbred C57BLNeoplasmsCell Line, TumorMiceProgrammed Cell Death 1 Receptor

Keywords

ImmunotherapyImmune systemBlockadeCytotoxic T cellCancer researchImmunologyBiologyCancer immunotherapyCytokineT cellInterferonReceptorIn vitro

Sustainable Development Goals

SDG 0: Good health and well-being